Indexado em
  • Banco de Dados de Periódicos Acadêmicos
  • Abra o Portão J
  • Genamics JournalSeek
  • JournalTOCs
  • Infraestrutura Nacional de Conhecimento da China (CNKI)
  • Scimago
  • Diretório de Periódicos de Ulrich
  • RefSeek
  • Universidade de Hamdard
  • EBSCO AZ
  • OCLC- WorldCat
  • publons
  • MIAR
  • Comissão de Bolsas Universitárias
  • Fundação de Genebra para Educação e Pesquisa Médica
  • Euro Pub
  • Google Scholar
Compartilhe esta página

Abstrato

Impact of Immunologic Discoveries on the Vaccine

Zelalem Kiros Bitsue*

The spike glycoprotein (S1) interacts with host cell epithelial Angiotensin-Converting Enzyme-2 (ACE-2) receptors. The nano-luciferase-based assay shows that the virus’s 1 protein has a strong binding affinity with the ACE-2 receptors. Reports illustrate the S-protein antigenic epitope of SARS-CoV-2 binds with the TLR4/ MD-2 complex by strong molecular bonding interactions. The pool of miRNA based studies shows that TMPRSS2 acts as promising regulators for the SARS-CoV-2 entry checkpoint. Recent report stated that the AT1R phosphorylates JAK2 in the lung cells, which activates STAT-3 transduction to the nucleus.

Not only I discovered vaccine AZEE CRA 01, immune cell principles and methods of vaccination but also B cells have two components. B cells synthesis both MHC I, and MHC II. CD4 interacts with MQ, MHC II, CD8 Interacts with DC, MHC I, and B cells interacts with both MHC I, and MHC II, and Th2 and Tc1 (CD4 and CD8).

In these original articles I report the pandemics and immune cells, immunologic clearance and immune mechanisms, the discovery process: innovation and immunology, zelalem kiros bitsue and his vaccine discoveries, zelalem kiros bitsue and his immunologic discoveries, vaccine discovered and mechanisms of action 1of 2.